Home
Conditions
Multiple Sclerosis, Relapsing-Remitting

Clinical trial condition

Multiple Sclerosis, Relapsing-Remitting

Explore clinical trials studying Multiple Sclerosis, Relapsing-Remitting. Study availability and eligibility vary by location and protocol.

167 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Multiple Sclerosis, Relapsing-Remitting trial results

Recruiting

Light Stimulation to Improve Visual Function After Optic Neuritis in Persons with Multiple Sclerosis

NCT06389968

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Cranial Nerve Diseases, +9 more
Locations: Technical University of Munich Munich, Bavaria, Germany

View Trial Details

Recruiting

Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands

NCT06567197

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Amsterdam UMC Amsterdam, Netherlands

St. Antonius Hospital Nieuwegein, Netherlands

View Trial Details

Recruiting

Development of Camera Based Gait Quality Measure for Persons With Multiple Sclerosis

NCT06516458

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Shirley Ryan AbilityLab Chicago, Illinois, United States

View Trial Details

Recruiting

MS-ResearchBiomarkerS

NCT05204459

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +26 more
Locations: Cedars-Sinai Medical Center Los Angeles, California, United States

View Trial Details

Recruiting

Biomarkers of aHSCT

NCT06195800

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, England, United Kingdom

View Trial Details

Recruiting

Non-inferiority Study of Rituximab Compared to Ocrelizumab in Relapsing MS

NCT05834855

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Brain Diseases, +8 more
Locations: Amsterdam UMC, location VUmc Amsterdam, Netherlands

View Trial Details

Recruiting

Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis

NCT04458688

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: Wayne State University Detroit, Michigan, United States

View Trial Details

Enrolling by Invitation

Effects of Ocrelizumab Treatment on Immune Cells in Lymph Nodes in Multiple Sclerosis

NCT06495593

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +5 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Not Yet Recruiting

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care

NCT07280871

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations: Centre Hospitalier de Luxembourg Luxembourg

View Trial Details

Not Yet Recruiting

Behavioral Intervention for Physical Activity and Sexual Dysfunction in Multiple Sclerosis

NCT04768777

Conditions: Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Behavior, +13 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Multiple Sclerosis, Relapsing-Remitting

Multiple Sclerosis, Relapsing-Remitting trial results

Related conditions